Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
QuintilesIMS
Daiichi Sankyo
Harvard Business School
Deloitte
Moodys
Covington
Cipla
Julphar

Generated: October 20, 2017

DrugPatentWatch Database Preview

Bionpharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?

BIONPHARMA INC has twenty-three approved drugs.

There is one US patent protecting BIONPHARMA INC drugs.

There are nine patent family members on BIONPHARMA INC drugs in eight countries and twenty-one supplementary protection certificates in eleven countries.

Summary for Applicant: Bionpharma Inc

International Patents:9
US Patents:1
Tradenames:24
Ingredients:20
NDAs:23
Drug Master File Entries: (click here to view)1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc
PARICALCITOL
paricalcitol
CAPSULE;ORAL202539-001Mar 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Bionpharma Inc
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
cetirizine hydrochloride
CAPSULE;ORAL022429-002Jul 23, 2009OTCYesYes► Subscribe► Subscribe► Subscribe
Bionpharma Inc
AMANTADINE HYDROCHLORIDE
amantadine hydrochloride
CAPSULE;ORAL078720-001May 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Bionpharma Inc
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
CAPSULE;ORAL022429-004Jul 23, 2009OTCYesYes► Subscribe► Subscribe► Subscribe
Bionpharma Inc
DUTASTERIDE
dutasteride
CAPSULE;ORAL200899-001Nov 20, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Bionpharma Inc
PROGESTERONE
progesterone
CAPSULE;ORAL200900-001Aug 16, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Bionpharma Inc
ZONISAMIDE
zonisamide
CAPSULE;ORAL077813-001Aug 16, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Bionpharma Inc
CETIRIZINE HYDROCHLORIDE ALLERGY
cetirizine hydrochloride
CAPSULE;ORAL022429-001Jul 23, 2009OTCYesNo► Subscribe► Subscribe► Subscribe
Bionpharma Inc
NIMODIPINE
nimodipine
CAPSULE;ORAL076740-001Jan 17, 2008ABRXNoYes► Subscribe► Subscribe► Subscribe
Bionpharma Inc
GRANISETRON HYDROCHLORIDE
granisetron hydrochloride
INJECTABLE;INJECTION078880-001Jun 30, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Bionpharma Inc Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)0115688► Subscribe
Austria357229► Subscribe
Japan2003508434► Subscribe
Germany60034044► Subscribe
Australia7094900► Subscribe
Australia780212► Subscribe
European Patent Office1207872► Subscribe
Poland362850► Subscribe
Canada2382292► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Bionpharma Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB98/013United Kingdom► SubscribePRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
C/GB03/018United Kingdom► SubscribePRODUCT NAME: DUTASTERIDE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SOLVATE.; REGISTERED: SE 17871 20020719; SE 17872 20020719; UK PL 19494/0005 20030117; UK PL 19494/0006 20030117
90013-1Sweden► SubscribePRODUCT NAME: NAPROXEN OCH ESOMEPRAZOL; NAT. REG. NO/DATE: MTNR 43248 20101203; FIRST REG.: GB PL 17901/0263 20101105
1411900/01Switzerland► SubscribePRODUCT NAME: ESOMEPRAZOL + NAPROXEN; REGISTRATION NO/DATE: SWISSMEDIC 61330 06.05.2011
C0037Belgium► SubscribePRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
00054Netherlands► SubscribePRODUCT NAME: BEXAROTENE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT OF IN DE VORM VAN EEN ESTER MET EEN HYDROXYVER- BINDING MET DE FORMULE R9OH, WAARIN R9 EEN; NAT. REGISTRATION NO/DATE: EU/1/01/178/001 20010329; FIRST REGISTRATION: EU/1/01/178/001 20010329
C/GB11/015United Kingdom► SubscribePRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
C/GB11/013United Kingdom► SubscribePRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
C/GB04/003United Kingdom► SubscribePRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721
2011005,C0984957Lithuania► SubscribePRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
US Army
Johnson and Johnson
AstraZeneca
Novartis
Fish and Richardson
UBS
McKesson
Fuji
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot